Annual Working Capital
$336.21 M
+$20.28 M+6.42%
December 31, 2023
Summary
- As of February 7, 2025, JANX annual working capital is $336.21 million, with the most recent change of +$20.28 million (+6.42%) on December 31, 2023.
- During the last 3 years, JANX annual working capital has risen by +$323.33 million (+2510.11%).
- JANX annual working capital is now -7.69% below its all-time high of $364.22 million, reached on December 31, 2021.
Performance
JANX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$649.15 M
-$1.25 M-0.19%
September 30, 2024
Summary
- As of February 7, 2025, JANX quarterly working capital is $649.15 million, with the most recent change of -$1.25 million (-0.19%) on September 30, 2024.
- Over the past year, JANX quarterly working capital has increased by +$308.42 million (+90.52%).
- JANX quarterly working capital is now -0.19% below its all-time high of $650.39 million, reached on June 30, 2024.
Performance
JANX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
JANX Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +6.4% | +90.5% |
3 y3 years | +2510.1% | +72.1% |
5 y5 years | +8570.9% | - |
JANX Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -7.7% | +6.4% | -0.2% | +122.8% |
5 y | 5-year | -7.7% | +8570.9% | -0.2% | +4939.6% |
alltime | all time | -7.7% | +8570.9% | -0.2% | +4939.6% |
Janux Therapeutics Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $649.15 M(-0.2%) |
Jun 2024 | - | $650.39 M(+0.4%) |
Mar 2024 | - | $648.06 M(+92.8%) |
Dec 2023 | $336.21 M(+6.4%) | $336.21 M(-1.3%) |
Sep 2023 | - | $340.72 M(+16.9%) |
Jun 2023 | - | $291.40 M(-4.5%) |
Mar 2023 | - | $305.29 M(-3.4%) |
Dec 2022 | $315.93 M | $315.93 M(-3.7%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $328.00 M(-4.9%) |
Jun 2022 | - | $345.07 M(-2.0%) |
Mar 2022 | - | $352.14 M(-3.3%) |
Dec 2021 | $364.22 M(+2727.6%) | $364.22 M(-3.4%) |
Sep 2021 | - | $377.12 M(-2.7%) |
Jun 2021 | - | $387.40 M(+500.5%) |
Mar 2021 | - | $64.51 M(+400.8%) |
Dec 2020 | $12.88 M(-424.5%) | $12.88 M |
Dec 2019 | -$3.97 M | - |
FAQ
- What is Janux Therapeutics annual working capital?
- What is the all time high annual working capital for Janux Therapeutics?
- What is Janux Therapeutics annual working capital year-on-year change?
- What is Janux Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Janux Therapeutics?
- What is Janux Therapeutics quarterly working capital year-on-year change?
What is Janux Therapeutics annual working capital?
The current annual working capital of JANX is $336.21 M
What is the all time high annual working capital for Janux Therapeutics?
Janux Therapeutics all-time high annual working capital is $364.22 M
What is Janux Therapeutics annual working capital year-on-year change?
Over the past year, JANX annual working capital has changed by +$20.28 M (+6.42%)
What is Janux Therapeutics quarterly working capital?
The current quarterly working capital of JANX is $649.15 M
What is the all time high quarterly working capital for Janux Therapeutics?
Janux Therapeutics all-time high quarterly working capital is $650.39 M
What is Janux Therapeutics quarterly working capital year-on-year change?
Over the past year, JANX quarterly working capital has changed by +$308.42 M (+90.52%)